Proteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy
Authors:
Open Access
- 18 April 2017
- journal article
- research article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 39 (6) , 1357-1370
Abstract
X-linked muscular dystrophy is caused by primary abnormalities in the Dmd gene and is characterized by the almost complete loss of the membrane cytoskeletal protein dystrophin, which triggers sarcolemmal instability, abnormal calcium homeostasis, increased proteolysis and impaired excitation‑contraction coupling. In addition to progressive necrosis, crucial secondary pathologies are represented by myofibrosis and the invasion of immune cells in damaged muscle fibres. In order to determine whether these substantial changes within the skeletal musculature are reflected by an altered rate of protein release into the circulatory system or other plasma fluctuations, we used label‑free mass spectrometry to characterize serum from the mdx‑4cv model of Duchenne muscular dystrophy. Comparative proteomics revealed a large number of increased vs. decreased protein species in mdx‑4cv serum. A serum component with greatly elevated levels was identified as the inflammation‑inducible plasma marker haptoglobin. This acute phase response protein is usually secreted in relation to tissue damage and sterile inflammation. Both immunoblot analyses and enzyme‑linked immunosorbent assays confirmed the increased concentration of haptoglobin in crude mdx‑4cv serum. This suggests that haptoglobin, in conjunction with other altered serum proteins, represents a novel diagnostic, prognostic and/or therapy‑monitoring biomarker candidate to evaluate the inflammatory response in the mdx‑4cv animal model of dystrophinopathy.Keywords
This publication has 89 references indexed in Scilit:
- Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicineEPMA Journal, 2013
- PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic treesNucleic Acids Research, 2012
- Secreted proteins as a fundamental source for biomarker discoveryProteomics, 2012
- A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top‐down and bottom‐up proteomic analysesProteomics, 2011
- Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile ProteinsJournal of Biomedicine and Biotechnology, 2010
- Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancerJournal of Translational Medicine, 2009
- Assessment of albumin removal from an immunoaffinity spin column: Critical implications for proteomic examination of the albuminome and albumin‐depleted samplesProteomics, 2009
- By‐passing the nonsense mutation in the 4CV mouse model of muscular dystrophy by induced exon skippingThe Journal of Gene Medicine, 2008
- Investigation of an albumin‐enriched fraction of human serum and its albuminomeProteomics – Clinical Applications, 2007
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976